Novartis submits second FDA application for CAR-T therapy Kymriah, this time in diffuse large B-cell lymphoma
October 31, 2017Manufacturing and Production, Sales and Marketing CAR-T, Kymriah, Novartis
Following the “historic” FDA approval of the company’s CAR-T therapy Kymriah (tisagenlecleucel) in the treatment of paediatric and young adults …
Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m
October 31, 2017Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Kirin, joint venture, pharma
Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …
Janssen’s Stelara shows improvement in Crohn’s symptoms within one week, new findings reveal
October 30, 2017Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma
Janssen has unveiled new data on Stelara (ustekinumab) in the treatment of patients with moderately to severely active Crohn’s disease …
MSD withdraws European application of Keytruda combo in lung cancer
October 30, 2017Sales and Marketing EMA, MSD, keytruda
MSD has been forced to withdraw its EU marketing application for Keytruda (pembrolizumab) in combination with pemetrexed and carboplatin as …
AstraZeneca licenses genetic disease drug to Mereo Biopharma for $5 million, becomes shareholder
October 30, 2017Sales and Marketing AstraZeneca, Mereo BioPharma, pharma
AstraZeneca has agreed to license AZD9668, its experimental drug for the treatment of alpha-1 antitrypsin deficiency, to Mereo Biopharma for …
Novartis to bolster oncology portfolio with $3.9 billion acquisition
October 30, 2017Sales and Marketing Advanced Acclerator Applications, Lutathera, Novartis, pharma
Novartis has announced its intention to acquire France’s Advanced Accelerator Applications (AAA) for $3.9 billion in a move to reinforce …
Samsung Biologics reinforces biologic manufacturing and development partnership with MSD
October 30, 2017Manufacturing and Production, Sales and Marketing Korea, MSD, Samsung BioLogics, pharma
Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …
Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says
October 30, 2017Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma
Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …
Collaboration in Biopharma
October 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague,
Top Ten most popular articles on Pharmafile.com this week
October 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …
NHS was crippled by “unsophisticated” cyber attack
October 27, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% …
Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl
October 27, 2017Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids
John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …
Celgene hikes price of Revlimid to mask poor Q3 results
October 27, 2017Medical Communications, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical
Celgene posted its Q3 results and investors did not react well – shares plunged 16% immediately, after the biotech cut …
AbbVie’s psoriasis drug smashes all endpoints
October 26, 2017Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab
AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …
Is the NHS prepared for the upcoming winter season?
October 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma
After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …
GSK eyes healthcare expansion, hits targets due to new drugs
October 26, 2017Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical
During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …
Pfizer to begin auction of consumer health division next month
October 26, 2017Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle
Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …
NHS patients could be offered Airbnb-like accommodation
October 26, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
In a sign of how desperate the hospital bed situation across the UK is, one council has looked into piloting …
Regeneron injects $100 million and 300 new roles into Irish production facility
October 26, 2017Manufacturing and Production Regeneron, Sanofi, manufacturing, pharma
Sanofi subsidiary Regeneron has announced its intention to expand its production plant in Limerick, Ireland – the largest scale bulk …
Mental health problems cause 300,000 to leave work each year
October 26, 2017Research and Development biotech, drugs, mental health, pharma, pharmaceutical
A report commissioned by Prime Minister, Theresa May, has found that 300,000 people are leaving their positions of work after …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
